Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study

Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study

Background: The aim of this study was to prospectively analyse, for the first time worldwide by in vivo clinical confocal microscopy (CCM), corneal side effects secondary to the use of epidermal growth factor receptor (EGFR) inhibitor depatuxizumab mafodotin (ABT-414) in a cohort of patients affecte...

Full description

Bibliographic Details
Main Authors: Raffaele Parrozzani, Giuseppe Lombardi, Edoardo Midena, Francesca Leonardi, Davide Londei, Marta Padovan, Mario Caccese, Giulia Marchione, Silvia Bini, Vittorina Zagonel, Luisa Frizziero
Format: Article
Language:English
Published: SAGE Publishing 2020-05-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835920907543

Internet

https://doi.org/10.1177/1758835920907543

Similar Items